Raia Drogasil S.A. (ADR)
General ticker "RADLY" information:
- Sector: Health Care
- Industry: Medical - Pharmaceuticals
- Capitalization: $5.9B (TTM average)
Raia Drogasil S.A. (ADR) follows the US Stock Market performance with the rate: 39.3%.
Estimated limits based on current volatility of 5.1%: low 4.17$, high 4.62$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-12-15, amount 0.03$ (Y2.61%)
- Price in estimated range
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.71$, 5.17$]
- 2025-12-31 to 2026-12-31 estimated range: [2.77$, 5.22$]
Financial Metrics affecting the RADLY estimates:
- Positive: with PPE of 27.2 at the end of fiscal year the price was very low
- Positive: -4.75 < Operating profit margin, % of 6.09
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 5.13
- Negative: Industry earnings per price (median), % of -16.99 <= 0
- Positive: 19.40 < Shareholder equity ratio, % of 29.03 <= 42.68
- Negative: negative Industry operating income (median)
- Negative: Operating cash flow per share per price, % of 5.39 <= 6.64
Short-term RADLY quotes
Long-term RADLY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | BRL33,973.79MM | BRL38,864.46MM | BRL43,381.23MM |
| Operating Expenses | BRL31,893.30MM | BRL36,497.28MM | BRL40,795.61MM |
| Operating Income | BRL2,080.49MM | BRL2,367.17MM | BRL2,585.62MM |
| Non-Operating Income | BRL-863.80MM | BRL-951.46MM | BRL-1,166.01MM |
| Interest Expense | BRL737.79MM | BRL812.72MM | BRL1,052.25MM |
| Income(Loss) | BRL1,216.69MM | BRL1,415.71MM | BRL1,419.61MM |
| Taxes | BRL129.55MM | BRL206.51MM | BRL144.91MM |
| Profit(Loss)* | BRL1,054.97MM | BRL1,197.69MM | BRL1,271.39MM |
| Stockholders Equity | BRL5,956.00MM | BRL6,428.77MM | BRL7,318.45MM |
| Inventory | BRL7,197.43MM | BRL8,407.43MM | BRL9,571.54MM |
| Assets | BRL20,094.41MM | BRL22,141.69MM | BRL25,461.04MM |
| Operating Cash Flow | BRL962.54MM | BRL1,912.58MM | BRL2,382.91MM |
| Capital expenditure | BRL1,304.58MM | BRL1,283.65MM | BRL1,375.42MM |
| Investing Cash Flow | BRL-1,307.03MM | BRL-1,412.91MM | BRL-1,378.13MM |
| Financing Cash Flow | BRL323.27MM | BRL-383.99MM | BRL-1,022.80MM |
| Earnings Per Share** | BRL0.62 | BRL0.73 | BRL0.77 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.